Received May 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | 1 | — | — |
Injection site swelling; nausea; vomiting; fever; erythema; hot at the injection site; This is a spontaneous report received from a Pharmacist. A 55-year-old female patient (not pregnant) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 29Apr2025 as dose 1, single (Batch/Lot number: unknown) at the age of 56 years for immunisation. The patient's relevant medical history included: "vaccination side effect" (unspecified if ongoing), notes: Has not done well with vaccines in general; similar reaction but not as extreme.; "Latex allergy" (unspecified if ongoing). Concomitant medication(s) included: METHOTREXATE. The following information was reported: VACCINATION SITE SWELLING (non-serious) with onset 30Apr2025, outcome "unknown", described as "Injection site swelling"; ERYTHEMA (non-serious) with onset 30Apr2025, outcome "unknown"; PYREXIA (non-serious) with onset 30Apr2025, outcome "unknown", described as "fever"; VACCINATION SITE WARMTH (non-serious) with onset 30Apr2025, outcome "unknown", described as "hot at the injection site"; NAUSEA (non-serious) with onset 30Apr2025, outcome "unknown"; VOMITING (non-serious) with onset 30Apr2025, outcome "unknown". It was unknown if therapeutic measures were taken as a result of vaccination site swelling, nausea, vomiting, pyrexia, erythema, vaccination site warmth. The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Latex allergy; Vaccination adverse reaction (Has not done well with vaccines in general; similar reaction but not as extreme.)
METHOTREXATE